Login / Signup

An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa--authors' response.

Burcu IslerPatrick N A HarrisAdam G StewartDavid L Paterson
Published in: The Journal of antimicrobial chemotherapy (2021)
Keyphrases
  • pseudomonas aeruginosa
  • multidrug resistant
  • escherichia coli
  • acinetobacter baumannii
  • cystic fibrosis
  • gram negative
  • klebsiella pneumoniae
  • current status
  • biofilm formation
  • drug resistant
  • staphylococcus aureus